USA flag logo/image

An Official Website of the United States Government

HUMAN PROSTATIC CANCER CELL CULTURES FOR DRUG EVALUATION

Award Information

Agency:
Department of Health and Human Services
Branch:
N/A
Award ID:
19131
Program Year/Program:
1992 / SBIR
Agency Tracking Number:
19131
Solicitation Year:
N/A
Solicitation Topic Code:
N/A
Solicitation Number:
N/A
Small Business Information
Biological Research Faculty &
10075-20 Tyler Pl Ijamsville, MD 21754
View profile »
Woman-Owned: No
Minority-Owned: Yes
HUBZone-Owned: No
 
Phase 1
Fiscal Year: 1992
Title: HUMAN PROSTATIC CANCER CELL CULTURES FOR DRUG EVALUATION
Agency: HHS
Contract: N/A
Award Amount: $50,000.00
 

Abstract:

THE OVERALL OBJECTIVE OF THIS PROJECT IS TO INCLUDE HUMAN PROSTATIC CANCER CELL LINES FOR DISCOVERING CANCER CHEMOTHERPAEUTIC DRUGS. SPECIFIC AIMS OF PHASE I INCLUDE ESTABLISHMENT AND CHARACTERIZATION OF NEW HUMAN PROSTATIC CANCER CELL STRAINS/LINES SUITABLE FOR DRUG EVALUATION. THESE STUDIES WILL INCLUDE THE USE OF SPECIAL CULTURE MEDIA AND EXPERIMENTAL CONDITIONS REQUIRED FOR ESTABLISHMENT OF THE FASTIDIOUS, YET URGENTLY NEEDED, PROSTATIC CANCER CELL LINES. DRUG SENSITIVITY DATA FROM CURRENTLY AVAILABLE PROSTATIC CANCER LINES WILL BE COMPARED, IN PHASE II, WITH SUCH DATA TO BE OBTAINED FROM A PANEL OF NEW CELL STRAINS/LINES DEVELOPED FROM INDIVIDUAL PATIENTS DURING PHASE I. THE MAIN TECHNICAL INNOVATION IN THIS PROJECT IS APPLICATION OF NEW STRATEGIES FOR ISOLATION AND CULTURE OF PROSTATIC CANCER CELLS. ALL PRODUCTS AND PROCEDURES DEVELOPED DURING PHASE I WILL BE FURTHER REFINED IN PHASE II THAT WOULD ENABLE THE DISCOVERY OF NEW DRUGS AGAINST PROSTATIC CANCER. BECAUSE OF THE HEALTH RELATEDNESS OF THIS PROJECT, IT IS HIGHLY RELEVANT TO THE MISSION AND OBJECTIVES OF THE NATIONAL INSTITUTES OF HEALTH.

Principal Investigator:

P Thomas Iype
3018318810

Business Contact:

Small Business Information at Submission:

Biological Research Faculty &
10075-20 Tyler Pl Ijamsville, MD 21745

EIN/Tax ID:
DUNS: N/A
Number of Employees: N/A
Woman-Owned: No
Minority-Owned: No
HUBZone-Owned: No